Molecular Structure
FDA Information
On June 14th 1996, the FDA first approved Pfizer’s Zmax® (azithromycin extended release) for oral suspension, a one-dose-only treatment for mild to moderate acute bacterial sinusitis caused by Haemophilus influenzae, Moraxella catarrhalis, or Streptococcus pneumoniae, and community-acquired pneumonia due to Chlamydophila pneumoniae, Haemophilus influenzae, Mycoplasma pneumoniae, or Streptococcus pneumoniae in adults.
Additionally, azithromycin was also approved for the prevention and treatment of Mycobacterium avium complex (MAC) in persons with advanced HIV infection.
Please visit the official site of the FDA for further information.
Why is this medication prescribed?
Dosage and using this medicine
What special precautions should I follow?
What should I do if I forget a dose?
What side effects can this medication cause?
What storage conditions are needed for this medicine?
In case of an emergency/overdose